Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sensors (Basel) ; 23(12)2023 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-37420584

RESUMO

Wide-range application scenarios, such as industrial, medical, rescue, etc., are in various demand for human spatial positioning technology. However, the existing MEMS-based sensor positioning methods have many problems, such as large accuracy errors, poor real-time performance and a single scene. We focused on improving the accuracy of IMU-based both feet localization and path tracing, and analyzed three traditional methods. In this paper, a planar spatial human positioning method based on high-resolution pressure insoles and IMU sensors was improved, and a real-time position compensation method for walking modes was proposed. To validate the improved method, we added two high-resolution pressure insoles to our self-developed motion capture system with a wireless sensor network (WSN) system consisting of 12 IMUs. By multi-sensor data fusion, we implemented dynamic recognition and automatic matching of compensation values for five walking modes, with real-time spatial-position calculation of the touchdown foot, enhancing the 3D accuracy of its practical positioning. Finally, we compared the proposed algorithm with three old methods by statistical analysis of multiple sets of experimental data. The experimental results show that this method has higher positioning accuracy in real-time indoor positioning and path-tracking tasks. The methodology can have more extensive and effective applications in the future.


Assuntos
Caminhada , Dispositivos Eletrônicos Vestíveis , Humanos , , Algoritmos , Captura de Movimento
2.
Materials (Basel) ; 16(8)2023 Apr 10.
Artigo em Inglês | MEDLINE | ID: mdl-37109839

RESUMO

Currently, mass concrete is increasingly utilized in various engineering projects that demand high physical properties of concrete. The water-cement ratio of mass concrete is comparatively smaller than that of the concrete used in dam engineering. However, the occurrence of severe cracking in mass concrete has been reported in numerous engineering applications. To address this issue, the incorporation of MgO expansive agent (MEA) in concrete has been widely recognized as an effective method to prevent mass concrete from cracking. In this research, three distinct temperature conditions were established based on the temperature elevation of mass concrete in practical engineering scenarios. To replicate the temperature increase under operational conditions, a device was fabricated that employed a stainless-steel barrel as the container for concrete, which was enveloped with insulation cotton for thermal insulation purposes. Three different MEA dosages were used during the pouring of concrete, and sine strain gauges were placed within the concrete to gauge the resulting strain. The hydration level of MEA was studied using thermogravimetric analysis (TG) to calculate the degree of hydration. The findings demonstrate that temperature has a significant impact on the performance of MEA; a higher temperature results in more complete hydration of MEA. The design of the three temperature conditions revealed that when the peak temperature exceeded 60 °C in two cases, the addition of 6% MEA was sufficient to fully compensate for the early shrinkage of concrete. Moreover, in instances where the peak temperature exceeded 60 °C, the impact of temperature on accelerating MEA hydration was more noticeable.

3.
Materials (Basel) ; 16(6)2023 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-36984247

RESUMO

The internal temperature of the mass concrete is not constant. In the actual project, the internal temperature of the concrete will experience a process of rapid warming to reach the peak temperature and then slow down. In this study, volume measurement method is used to simulate the internal volume deformation of mass concrete under actual engineering conditions. The embedded strain gauge was embedded in concrete with a water-cement ratio of 0.32 for 28 days, and the development of total volume deformation and autogenous volume deformation of concrete under variable temperature conditions was studied by external heating of concrete. The results show that the finer the cement, the earlier the concrete starts to shrink, and the greater the total shrinkage of the concrete. The high temperature will promote the hydration of cement with different fineness and will reduce the total porosity of their paste, but the proportion of harmful pores in the paste with finer cement particles is lower.

4.
J Thromb Haemost ; 18(5): 1094-1099, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-32220112

RESUMO

BACKGROUND: A relatively high mortality of severe coronavirus disease 2019 (COVID-19) is worrying, and the application of heparin in COVID-19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism. However, its efficacy remains to be validated. METHODS: Coagulation results, medications, and outcomes of consecutive patients being classified as having severe COVID-19 in Tongji hospital were retrospectively analyzed. The 28-day mortality between heparin users and nonusers were compared, as was a different risk of coagulopathy, which was stratified by the sepsis-induced coagulopathy (SIC) score or D-dimer result. RESULTS: There were 449 patients with severe COVID-19 enrolled into the study, 99 of them received heparin (mainly with low molecular weight heparin) for 7 days or longer. D-dimer, prothrombin time, and age were positively, and platelet count was negatively, correlated with 28-day mortality in multivariate analysis. No difference in 28-day mortality was found between heparin users and nonusers (30.3% vs 29.7%, P = .910). But the 28-day mortality of heparin users was lower than nonusers in patients with SIC score ≥4 (40.0% vs 64.2%, P = .029), or D-dimer >6-fold of upper limit of normal (32.8% vs 52.4%, P = .017). CONCLUSIONS: Anticoagulant therapy mainly with low molecular weight heparin appears to be associated with better prognosis in severe COVID-19 patients meeting SIC criteria or with markedly elevated D-dimer.


Assuntos
Anticoagulantes/uso terapêutico , Betacoronavirus , Biomarcadores/sangue , Infecções por Coronavirus , Coagulação Intravascular Disseminada , Heparina de Baixo Peso Molecular/uso terapêutico , Pandemias , Pneumonia Viral , Fatores Etários , Idoso , Anticoagulantes/administração & dosagem , Testes de Coagulação Sanguínea , COVID-19 , Infecções por Coronavirus/complicações , Infecções por Coronavirus/tratamento farmacológico , Infecções por Coronavirus/mortalidade , Coagulação Intravascular Disseminada/tratamento farmacológico , Coagulação Intravascular Disseminada/etiologia , Feminino , Produtos de Degradação da Fibrina e do Fibrinogênio , Heparina de Baixo Peso Molecular/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Contagem de Plaquetas , Pneumonia Viral/complicações , Pneumonia Viral/tratamento farmacológico , Pneumonia Viral/mortalidade , Prognóstico , Tempo de Protrombina , Estudos Retrospectivos , SARS-CoV-2 , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...